Latest Interviews
Showing 16–20 of 20 transcripts.
Clear all filters- Goldman Sachs9 min
Takeaways from the 24th European Financials Conference
The 24th annual European Financials Conference gathered executives from major banks, insurers, and real estate firms to discuss a crisis consensus on severity that exceeds the 2008 and 2012 downturns. While policymakers and bank leaders project an optimistic recovery for 2021–2022, investors remain skeptical, particularly regarding dynamic capital adequacy needed to fund the economic rebound. Key debates centered on managing excess liquidity and determining the optimal timing for dividend resumption, as uncertainties over lockdown durations and Brexit outcomes obscure precise credit loss forecasts.
- Goldman Sachs11 min
The Scale and State of the Semiconductor Industry
Facing a projected 10% semiconductor industry decline in 2020 driven by pandemic-induced global GDP contraction, market dynamics have diverged with robust cloud computing demand offsetting weakness in handsets and automotive sectors. While the supply chain demonstrated unexpected resilience outside of specific disruptions in Wuhan, Malaysia, and the Bay Area, geopolitical trade restrictions and US-China tensions continue to create significant regulatory uncertainty for major OEMs like Huawei. Simultaneously, competitive pressures have intensified as top buyers consolidate purchasing power and tech giants vertically integrate their chip designs, shifting the battlefield toward advanced manufacturing triopolies and diversified data center compute cycles.
- Goldman Sachs7 min
Accelerated Innovation in the Healthcare Industry
Driven by unprecedented government-industry collaboration and $3 billion in BARDA funding, the medical sector is compressing vaccine development timelines from four years to eighteen months while restructuring healthcare delivery through permanent telemedicine and domestic supply chain priorities. Concurrently, plummeting genome sequencing costs are accelerating research into gene and cell therapies for rare diseases, while robotic surgery adoption enhances ICU surge capacity and patient recovery rates. This convergence of policy support, financial investment, and technological integration has created the most favorable investment environment in history, signaling a decade-long trajectory of rapid innovation in genomics and next-generation medicine.
- Goldman Sachs8 min
The Evolution of Europe’s Tech Landscape
European technology companies have leveraged robust pre-existing infrastructure to maintain business continuity while accelerating market trends like e-commerce adoption and digital collaboration tools. This sector is simultaneously experiencing a surge in private unicorns and capital availability driven by returning executives and a shift toward ambitious global valuations. Although currently underweighted in public markets compared to the U.S., a wave of high-profile listings and deal activity across defensive, opportunistic, and strategic phases signals a maturing ecosystem.
- Goldman Sachs10 min
The Outlook for the Corporate Credit Default Cycle
Goldman Sachs identified three sequential credit risks in early March, noting that Federal Reserve intervention in late March successfully mitigated the most severe credit crunch and liquidity impairment while leaving fundamental financial distress intact. Although the central bank's announcement triggered an 85% surge in primary market issuance and normalized secondary trading conditions, the firm maintains a 13% default rate forecast for the year due to persistent earnings pressure on lower-rated issuers. Market participants anticipate a strategic shift toward restructurings rather than liquidations, with a projected sector rotation back into cyclical industries like energy as the economic recovery progresses.